InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.69
(
-1.57%
)
US TECH 100
16,921.60
(
-2.24%
)
Dow Jones
37,815.92
(
-1.49%
)
Brent Oil
85.90
(
-1.59%
)
Bitcoin
60,589.99
(
-5.09%
)
Post# of 251653
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119515
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 234845

Thursday, 04/11/2024 5:53:10 PM

Thursday, April 11, 2024 5:53:10 PM

Post# of 251653
ENLV—(-54%)—reports purportedly-positive phase-2 data in sepsis:

https://finance.yahoo.com/news/enlivex-announces-topline-results-phase-120500002.html

Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, today announced positive indication of effect and safety results from its Phase II study of Allocetra in patients with sepsis, in which 120 patients enrolled.

LOL re the use of the phrase, “positive indication of effect.”

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up